Evidence map›Paper›PMID 28282067›Full record

Observational studyEye (London, England)2017

Evaluation of dry eye and meibomian gland dysfunction with meibography in vitiligo.

M Palamar, P Kiyat, I Ertam, A Yagci

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Eye (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Translating Biomarker Discovery: From Bench to Bedside in Dry Eye Disease.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Dry Eye and Meibomian Glands in VitiligoTurkish journal of ophthalmology · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M PalamarDepartment of Ophthalmology, Ege University Faculty of Medicine, Izmir, Turkey.
P KiyatDepartment of Ophthalmology, Ege University Faculty of Medicine, Izmir, Turkey.
I ErtamDepartment of Dermatology, Ege University Faculty of Medicine, Izmir, Turkey.
A YagciDepartment of Ophthalmology, Ege University Faculty of Medicine, Izmir, Turkey.
Ege University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PurposeTo evaluate the dry eye and meibomian gland dysfunction (MGD) of vitiligo patients with meibography.MethodsTwenty eyes of 20 vitiligo patients (Group 1) and 20 eyes of 20 healthy individuals (Group 2) were enrolled. All subjects had undergone a comprehensive ophthalmic examination including corneal and conjunctival fluorescein staining (Oxford scale scoring), tear film break-up time (T-BUT), Schirmer 1 test, Ocular Surface Disease Index (OSDI) score assessment, and upper and lower eyelid meibography using infrared captures of a biomicroscope (Topcon, SL-D701, IJssel, The Netherlands). Partial or complete loss of the meibomian glands was scored for each eyelid from grade 0 (no loss) through grade 3 (lost area was >2/3 of the total meibomian gland area).ResultsThe mean ages of Group 1 and Group 2 were 35.5±13.4 (range, 8-54) and 35.2±12.4 years (range, 8-52), respectively (P=0.942). Mean Schirmer 1 values were lower, and Oxford score, OSDI score, and meiboscores of lower eyelids were higher in Group 1, but the difference was not statistically significant (P=0.139, P=0.057, P=0.071, P=0.300, respectively). T-BUT values were significantly lower, and meiboscores of upper eyelids and total (upper+lower) eyelids were significantly higher in Group 1 than in Group 2 (P=0.047, P=0.001, P=0.003, respectively).ConclusionVitiligo can be associated with dry eye and there are significant differences in meibomian gland morphology in patients with vitiligo when compared with healthy subjects. For this reason, patients with vitiligo should be monitored for dry eye and MGD, and promptly start treatment when needed.

Indexed as

Diagnostic Techniques, OphthalmologicalAdolescentAdultChildConjunctivaCorneaCross-Sectional StudiesDry Eye SyndromesEyelidsFemaleHumansMaleMeibomian GlandsMicroscopy, AcousticMiddle AgedVitiligo

Identifiers

PMID28282067
PMCPMC5519278
OpenAlexW2594699792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.